FDA approves Garzulys (insulin aspart-fsan) as a rapid-acting biosimilar to NovoLog for adult and pediatric patients with diabetes mellitus.
Elevated herpesvirus-directed responses and antiflagellin antibodies seen up to 10 years prediagnosis in Crohn disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results